Across TCGA pan-cancer cohorts, CDY22P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated CDY22P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher CDY22P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CDY22P expression acts as an unfavorable survival marker.

STAD are the cancer types where CDY22P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.074	0.688	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: CDY22P tumor-vs-normal RNA expression · all CDY22P data types